IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3014% above fair value
$257.60−7.13 (-2.69%)
Close on Nov 17, 2026Market cap $42.45BP/E 31.3Yield –
Iqvia price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Iqvia's price to sales ratio was 2.7× on Nov 11, 2026, against 2.5× a year earlier. Over the last 5 years it ranged from 1.6× to 4.0×, with a median of 2.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.7× | +0.2 |
| 2025 | Dec 31, 2025 | 2.4× | +0.1 |
| 2024 | Dec 31, 2024 | 2.3× | −0.5 |
| 2023 | Dec 29, 2023 | 2.8× | +0.2 |
| 2022 | Dec 30, 2022 | 2.7× | −1.3 |
| 2021 | Dec 31, 2021 | 4.0× | +0.8 |
| 2020 | Dec 31, 2020 | 3.1× | +0.3 |
| 2019 | Dec 31, 2019 | 2.9× | +0.5 |
| 2018 | Dec 31, 2018 | 2.4× | −0.1 |
| 2017 | Dec 29, 2017 | 2.5× | +0.5 |
| 2016 | Dec 30, 2016 | 2.0× | +0.0 |
| 2015 | Dec 31, 2015 | 2.0× | +0.2 |
| 2014 | Dec 31, 2014 | 1.8× | +0.2 |
| 2013 | Dec 31, 2013 | 1.6× | – |
See a number that looks wrong?